Category Archives: Europe

UK: Further Steps Toward Value-Based Assessment

By Leela Barham. The National Institute for Health and Care Excellence (NICE) has finally published the formal consultation on value-based assessment (VBA). VBA is the new VBP, incorporating a wider assessment of value and no longer clearly linking to price in quite the way that some speculated all the way back in 2010 when VBP […]
Also posted in Guest Blog, Op-Ed, pricing, Regulatory | Tagged , , , , , , | Leave a comment

Making the Most of Disruptive Digital Technologies

Peter Houston looks at the pharma marketing takeaways from last week’s Digital Innovation Summit.
Also posted in E-Media, Events, Global, Marketing, multimedia, Op-Ed, social media, Technology | Tagged , , , | Leave a comment

EGA Calls for Removal of Barriers to Generics in Europe

Adrian van den Hoven, Director General of the European Generics Association (EGA), this week called for the removal of barriers to generic medicines across the European Union.
Also posted in Events, Global, Regulatory | Tagged , , , , | Leave a comment

Biotech Industry Calls for Pan-European Tax Incentives

Europe’s biotech industry body, EuropaBio, has launched a report urging European governments to remain committed to biotech research, development and innovation (RDI) incentives, following release of the European Commission’s (EC) 2014 Innovation Scoreboard.
Also posted in Biotech, Global, R&D, Regulatory | Tagged , , , , , | Leave a comment

Allergy Shots in a Pill?

Allergy season’s dank fecundity might be welcomed in many parts of America this year. Anything that’s warmer. But the worst allergy sufferers might soon be headed back to the doctor’s office for another round of allergy shots. Or perhaps not. ALK-Abelló, a Denmark-based specialty pharmaceuticals company focused solely on allergy immunotherapy products, expects FDA to […]
Also posted in Biotech, FDA, R&D, Regulatory, Strategy, Technology | Tagged , , , , , , , , , | Leave a comment
  • Categories

  • Meta